Latest news
Symposium series | Optimizing treatment for chronic lymphocytic leukemia with BTK inhibitors - Lymphoma HubLymphoma Hub · Fri, 07 Aug 2026 19:18:15 GMTNew BTK Inhibitor Approved for Urticaria - MedscapeMedscape · Fri, 07 Aug 2026 14:53:14 GMTComparing CV Safety and Exploratory Bleeding Outcomes of BTK Inhibitors in Mantle Cell Lymphoma - The American Journal of Managed CareThe American Journal of Managed Care · Wed, 05 Aug 2026 20:44:48 GMTCombining BTK and BCL2 Inhibitors in Mantle Cell Lymphoma: Eyre Weighs in on Where the Field Goes Next - The American Journal of Managed CareThe American Journal of Managed Care · Wed, 05 Aug 2026 20:31:11 GMTDr Mulvey on Real-World Treatment Discontinuation Data for First-Line BTK Inhibitors in CLL - OncLiveOncLive · Wed, 05 Aug 2026 03:19:51 GMTBTK Inhibitors in Chronic Lymphocytic Leukemia: Current Practice and Future Perspectives - OncodailyOncodaily · Mon, 03 Aug 2026 00:05:55 GMTSymposium | BTK inhibitors in practice: Treatment selection and emerging clinical evidence - Lymphoma HubLymphoma Hub · Fri, 31 Jul 2026 07:00:00 GMTSymposium | BTK inhibitors in CLL: Mechanisms, clinical considerations, and unmet needs - Lymphoma HubLymphoma Hub · Wed, 29 Jul 2026 15:38:50 GMT